TrialThe oncologist2024

Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study.

Min Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.